{"Symbol": "AURA", "AssetType": "Common Stock", "Name": "Aura Biosciences Inc", "Description": "Aura Biosciences Inc is a clinical-stage biotechnology company dedicated to revolutionizing cancer treatment through its proprietary virus-like particle (VLP) technology. The company\u2019s lead therapeutic candidate, AU-011, specifically targets ocular cancers by selectively destroying tumor cells while preserving adjacent healthy tissues. Aura is advancing its clinical pipeline to address critical unmet needs in oncology, supported by a strong management team and strategic partnerships. With a focus on innovation and a commitment to rigorous clinical trials, Aura Biosciences is well-positioned as a leader in the development of targeted cancer therapies in a rapidly evolving market.", "CIK": "1501796", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "80 GUEST STREET, BOSTON, MA, UNITED STATES, 02135", "OfficialSite": "https://www.aurabiosciences.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "353713000", "EBITDA": "-112213000", "PERatio": "None", "PEGRatio": "None", "BookValue": "2.487", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-1.91", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.358", "ReturnOnEquityTTM": "-0.643", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-1.91", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "20.2", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "5", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "2.266", "EVToRevenue": "-", "EVToEBITDA": "-5.68", "Beta": "0.457", "52WeekHigh": "8.03", "52WeekLow": "4.345", "50DayMovingAverage": "5.69", "200DayMovingAverage": "6.07", "SharesOutstanding": "63503000", "SharesFloat": "36616600", "PercentInsiders": "1.866", "PercentInstitutions": "82.573", "DividendDate": "None", "ExDividendDate": "None"}